EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Impact of Brain‐Derived Neurotrophic Factor rs6265 ( Val66Met ) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy–Genotype Interactions

Jordan B Walters, Maria J Quezada iD, Suning He, Ciara S Haynes, Kathy Steece-Collier, Timothy J Collier, Caryl E Sortwell, Colin K Franz

Muscle & Nerve · 2025

DOI: 10.1002/mus.28409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Jordan B Walters und 7 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Nerve Regeneration, Polymorphism, Single Nucleotide, Electric Stimulation Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Neuromuscular Foundation, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Therapeutic electrical stimulation (TES) shows promise in enhancing nerve regeneration, but outcomes vary widely. This study investigates the impact of the rs6265 single nucleotide polymorphism (SNP) on TES efficacy in a preclinical rat model and human stem cell‐derived motor neurons.

Methods

Wild‐type (WT) and rs6265 variant rats underwent sciatic nerve transection and received either TES or sham treatment. Muscle reinnervation was assessed through compound muscle action potentials and muscle fiber cross‐sectional area. Isogenic human iPSC‐derived motor neurons were used to study activity‐dependent brain‐derived neurotrophic factor (BDNF) secretion.

Results

WT rats that received TES (WT Estim) showed improved muscle cross‐sectional area, electrophysiological muscle reinnervation, muscle fiber size, and NMJ reinnervation compared to Sham [ p = 0.0468, p < 0.0001, p = 0.0160, p < 0.0001, respectively]. In contrast, rs6265 allele carriers did not experience a benefit of TES (rs6265 Estim) when compared to the Sham treatment [ p = 0.9754, p = 0.8606, p = 0.9815, p = 0.1047, respectively]. Additionally, rs6265 allele carriers exhibited impaired activity‐dependent BDNF secretion in vitro.

Discussion

The rs6265 polymorphism influences TES efficacy, highlighting the need for personalized approaches in peripheral nerve injury (PNI) treatment. These findings suggest that genetic screening could optimize therapeutic outcomes. Understanding genetic factors affecting TES response can enhance treatment strategies for PNI, potentially improving patient recovery and reducing outcome variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Derived Neurotrophic FactorNerve RegenerationPolymorphism, Single NucleotideElectric Stimulation TherapyPeripheral Nerve InjuriesAnimalsRatsHumansMaleInduced Pluripotent Stem CellsMotor NeuronsGenotypeRats, Sprague-DawleySciatic NerveAction PotentialsFemale

Stichwörter der Autor:innen

BDNF Val66MetBDNF rs6265nerve regenerationperipheral nerve injurytherapeutic electrical stimulation

Substanzen

Brain-Derived Neurotrophic FactorBDNF protein, human

Autor:innen und Institutionen

  • Regenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, Illinois, USA.
  • Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.
  • Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
  • Hauenstein Neuroscience Center, Mercy Health Saint Mary's, Grand Rapids, Michigan, USA.
  • Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Maria J Quezada

Förderung

  • American Neuromuscular Foundation
  • NIH HHS
  • NCI NIH HHS
  • Belle Carnell Regenerative Neurorehabilitation Fund
  • NINDS NIH HHS
  • National Institutes of Health

Zitieren

APA

Walters, J. B., Quezada, M. J., He, S., Haynes, C. S., Steece-Collier, K., Collier, T. J., Sortwell, C. E., & Franz, C. K. (2025). The Impact of Brain‐Derived Neurotrophic Factor rs6265 ( Val66Met ) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy–Genotype Interactions. Muscle & Nerve. https://doi.org/10.1002/mus.28409

Vancouver

Walters JB, Quezada MJ, He S, Haynes CS, Steece-Collier K, Collier TJ, et al. The Impact of Brain‐Derived Neurotrophic Factor rs6265 ( Val66Met ) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy–Genotype Interactions. Muscle & Nerve. 2025. doi:10.1002/mus.28409

BibTeX
@article{Walters2025,
  author = {Walters, Jordan B and Quezada, Maria J and He, Suning and Haynes, Ciara S and Steece-Collier, Kathy and Collier, Timothy J and Sortwell, Caryl E and Franz, Colin K},
  title = {The Impact of Brain‐Derived Neurotrophic Factor rs6265 ( Val66Met ) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy–Genotype Interactions},
  journal = {Muscle & Nerve},
  year = {2025},
  doi = {10.1002/mus.28409}
}
Kostenlos starten →